106 related articles for article (PubMed ID: 15818621)
1. Endogenous immune response to gangliosides in patients with confined prostate cancer.
Ravindranath MH; Muthugounder S; Presser N; Ye X; Brosman S; Morton DL
Int J Cancer; 2005 Sep; 116(3):368-77. PubMed ID: 15818621
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
[TBL] [Abstract][Full Text] [Related]
3. Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer.
Ravindranath MH; Muthugounder S; Presser N; Selvan SR; Portoukalian J; Brosman S; Morton DL
Biochem Biophys Res Commun; 2004 Nov; 324(1):154-65. PubMed ID: 15464996
[TBL] [Abstract][Full Text] [Related]
4. Immunogenic gangliosides in human ovarian carcinoma.
Ravindranath MH; Muthugounder S; Presser N; Selvan SR; Santin AD; Bellone S; Saravanan TS; Morton DL
Biochem Biophys Res Commun; 2007 Feb; 353(2):251-8. PubMed ID: 17188646
[TBL] [Abstract][Full Text] [Related]
5. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
6. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of melanoma-associated gangliosides in cancer patients.
Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
[TBL] [Abstract][Full Text] [Related]
9. Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma.
Ene CD; Tampa M; Nicolae I; Mitran CI; Mitran MI; Matei C; Caruntu A; Caruntu C; Georgescu SR
J Immunol Res; 2020; 2020():2491265. PubMed ID: 32855975
[TBL] [Abstract][Full Text] [Related]
10. Significance of endogenous augmentation of antiganglioside IgM in cancer patients: potential tool for early detection and management of cancer therapy.
Ravindranath MH; Muthugounder S; Hannah MR; Morton DL
Ann N Y Acad Sci; 2007 Jun; 1107():212-22. PubMed ID: 17804549
[TBL] [Abstract][Full Text] [Related]
11. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside reactive antibodies of IgG and IgM class in sera of patients with differentiated thyroid cancer.
Lewartowska A; Pacuszka T; Adler G; Panasiewicz M; Wojciechowska W
Immunol Lett; 2002 Feb; 80(2):129-32. PubMed ID: 11750045
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses to ganglio-series gangliosides in different strains of inbred mice.
Kawashima I; Nakamura O; Tai T
Mol Immunol; 1992 May; 29(5):625-32. PubMed ID: 1584231
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
[TBL] [Abstract][Full Text] [Related]
16. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
[TBL] [Abstract][Full Text] [Related]
17. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L
Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936
[TBL] [Abstract][Full Text] [Related]
18. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
19. Sensorimotor demyelinating neuropathy with IgM antibody against gangliosides GD1a, GT1b and GM3.
Mizutani K; Oka N; Kusunoki S; Kaji R; Mezaki T; Akiguchi I; Shibasaki H
J Neurol Sci; 2001 Jul; 188(1-2):9-11. PubMed ID: 11489278
[TBL] [Abstract][Full Text] [Related]
20. Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited.
Kollewe K; Wurster U; Sinzenich T; Körner S; Dengler R; Mohammadi B; Petri S
PLoS One; 2015; 10(4):e0125339. PubMed ID: 25875836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
